Status:

COMPLETED

SuPr Study (Supine Versus Prone Treatment Position in Breast Radiotherapy)

Lead Sponsor:

Royal Marsden NHS Foundation Trust

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Phase:

PHASE3

Brief Summary

A randomised, two-arm, non-blinded crossover study investigating the impact of treatment position (prone versus supine) upon reproducibility of tumour bed position in patients undergoing breast radiot...

Detailed Description

To establish whether or not the prone (face down) position reduces exposure of healthy tissue to radiation when compared to the supine position. To compare patient comfort and acceptability in each of...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Complete microscopic excision of early stage invasive ductal or lobular carcinoma (pT1-3b N0-1 M0) with breast preservation.
  • Paired titanium clips marking anterior, posterior, and radial walls of excision cavity
  • Breast cup size C or above
  • Recommendation for whole breast radiotherapy
  • No requirement for nodal irradiation
  • Ability to lie prone on breast board
  • For left-sided breast cancer patients, cardiac and LAD doses must be ≤10% greater than those predicted for the supine position.
  • For all patients, the following absolute dose constraints should be met: ≤5% of heart volume to receive 18Gy and ≤10% of ipsilateral lung volume to receive ≥20Gy
  • Age ≥18
  • PS ≤1
  • No previous radiotherapy to the affected breast
  • No concomitant herceptin
  • Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.
  • Written informed consent given according to ICH/GCP before registration/ randomisation.
  • Patients can only be randomised into this trial once.

Exclusion

    Key Trial Info

    Start Date :

    November 1 2008

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 1 2009

    Estimated Enrollment :

    25 Patients enrolled

    Trial Details

    Trial ID

    NCT01001728

    Start Date

    November 1 2008

    End Date

    November 1 2009

    Last Update

    May 23 2016

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Royal Marsden NHS Foundation Trust

    Sutton, Surrey, United Kingdom, SM2 5PT